MF

Mediolanum Farmaceutici S.p.A.

Europe, Lombardia, Italy, Milan

Description

Mediolanum Farmaceutici S.p.A. is an international pharmaceutical company

Investor Profile

Mediolanum Farmaceutici S.p.A. has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mediolanum Farmaceutici S.p.A. frequently co-invest with?

UI Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 1

Which angels does Mediolanum Farmaceutici S.p.A. often collaborate with?

GA
Europe, Ile-de-France, France, Paris
Shared Deals: 1
AM
Europe, Bourgogne, France, Dijon
Shared Deals: 1

What are some of recent deals done by Mediolanum Farmaceutici S.p.A.?

Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityMar 15, 2024
Amount Raised: $8,712,224
Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityMar 9, 2023
Amount Raised: $12,914,987